|
|
|
dietary reference intake (DRI) |
|
Diethylcarbamazine, for filariasis |
|
diffuse alveolar hemorrhage (DAH) |
|
|
|
Diffuse White Matter Disease |
|
|
|
|
|
|
|
|
|
Dihydropyridine, for vasospastic disorders |
|
|
|
|
|
|
|
Dimethyl fumarate, for multiple sclerosis |
|
dimethyltryptamine (DMT) |
|
Dioctyl sodium sulfosuccinate, for hemorrhoids |
|
DIP (desquamative interstitial pneumonia) |
|
dipeptidyl peptidase IV (DPP-IV) inhibitors, for diabetes mellitus |
|
|
|
|
|
|
|
|
|
Diphtheria-tetanus vaccine |
|
|
|
|
|
|
|
|
|
|
|
disease-modifying antirheumatic drugs (DMARDs), for rheumatoid arthritis |
